ABIVAX Soci?t? Anonyme - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABVX Nasdaq 2836 www.abivax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ABIVAX Soci?t? Anonyme

Abivax Presents Third Quarter 2025 Financial Results - Dec 15th, 2025 2:08 pm
2 Under-the-Radar Stocks That Have Soared This Year - Dec 9th, 2025 3:05 pm
The 1,300% Biotech Shockwave That Turned $500 Million Into $8 Billion - Dec 4th, 2025 10:54 am
Europe’s Biotech Standout Faces Crucial Year After 1,300% Rally - Dec 3rd, 2025 10:00 pm
Assessing Valuation: ABIVAX (ENXTPA:ABVX) Shares Surge 57% Over 90 Days - Nov 16th, 2025 9:07 am
Medicxi Announces €500 Million Fund V - Nov 14th, 2025 1:00 am
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - Nov 13th, 2025 10:00 am
Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year? - Nov 13th, 2025 7:40 am
Caterpillar upgraded, Elf Beauty downgraded: Wall Street's top analyst calls - Nov 6th, 2025 7:45 am
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis - Nov 3rd, 2025 2:05 pm
Barclays Initiates ABIVAX Société (ABVX) With Overweight Rating - Oct 19th, 2025 1:09 am
A Look at Abivax (ENXTPA:ABVX) Valuation Following Phase 3 Success for Obefazimod in Ulcerative Colitis - Oct 9th, 2025 5:08 pm
Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease - Oct 6th, 2025 3:17 pm
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid AMD-OpenAI AI Chip Deal, Rate Cut Hopes - Oct 6th, 2025 6:53 am
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies - Oct 6th, 2025 2:00 am
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data - Oct 5th, 2025 9:00 am
Citizens JMP Raises PT on ABIVAX Société Anonyme (ABVX) Stock - Oct 1st, 2025 12:27 am
ABIVAX Société Anonyme (ABVX) to Present Phase 3 UC Data at UEG Congress, Investor Call Scheduled - Sep 30th, 2025 10:47 am
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting - Sep 29th, 2025 2:05 pm
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting - Sep 23rd, 2025 2:05 pm